-+ 0.00%
-+ 0.00%
-+ 0.00%

Izumi (TSE:8273) Stock EPS Rebound Tests Bearish Long Term Narratives After Q1 2027 Results

Simply Wall St·07/16/2026 08:28:40
語音播報

Izumi (TSE:8273) has opened Q1 2027 with revenue of ¥140.3 billion and basic EPS of ¥21.55, setting the tone for how the year is starting to shape up for holders of the stock. The company has seen quarterly revenue move from ¥122.1 billion in Q1 2026 to ¥195.7 billion in Q4 2026, while basic EPS shifted from ¥18.97 to ¥27.28 over the same stretch, giving investors a clear view of how the top line and EPS have tracked into this latest print. With trailing net profit margins edging higher over the past year, the focus now is on how durable that profitability looks as these results roll into expectations for the rest of the year.

See our full analysis for Izumi.

With the headline numbers on the table, the next step is to weigh them against the most common stories around Izumi, highlighting where the latest results support those narratives and where they start to push back.

Curious how numbers become stories that shape markets? Explore Community Narratives

TSE:8273 Revenue & Expenses Breakdown as at Jul 2026
TSE:8273 Revenue & Expenses Breakdown as at Jul 2026

Margins Firm Up With 2.9% Net Profit Level

  • On a trailing twelve month basis, Izumi is earning net income of ¥17,317 million on revenue of ¥587,564 million, which works out to a 2.9% net profit margin compared with 2.4% a year earlier.
  • What stands out for the bullish narrative around Izumi is that earnings quality is described as high, with earnings up 43.9% over the past year even though the five year trend shows an average annual decline of 12.7%. This sets up a contrast between the recent margin uplift and the longer period of softer profits.
    • Supporters can point to the move in trailing revenue from ¥524,142 million in the year to Q4 2025 to ¥587,564 million in the year to Q1 2027 as evidence that the current margin level is being earned on a larger sales base than before.
    • Skeptics may focus on the fact that net income over the same trailing period is ¥17,317 million compared with ¥11,919 million in the year to Q4 2025, arguing that investors should still remember how weak profitability looked earlier in the period when judging how durable the recent margin profile might be.

EPS Trend Improves Against Five Year Record

  • Over the trailing twelve months to Q1 2027, basic EPS stands at ¥247.76 compared with ¥55.53 in the twelve months to Q4 2025. Within that period, quarterly EPS moved from ¥0.28 in Q4 2025 to a range between ¥14.24 and ¥27.28 across 2026, before coming in at ¥21.55 in Q1 2027.
  • Bears argue that Izumi still carries a weak long term track record because EPS is described as having declined an average of 12.7% per year over five years. The current twelve month EPS of ¥247.76 therefore tests whether the recent step up is a short term rebound or a reset in the company’s earning power.
    • The negative five year EPS trend sits in clear contrast to the one year earnings growth figure of 43.9%, so critics may highlight the risk that the shorter term strength is being measured off a low base that included the very soft Q4 2025 EPS of just ¥0.28.
    • At the same time, the sequence from ¥18.97 EPS in Q1 2026 to ¥27.28 in Q4 2026 and ¥21.55 in Q1 2027 gives investors a more recent run of quarters to compare against the long run average and decide how much weight to put on the older weak years.

Izumi Valuation, P/E 12x With 3.04% Yield

  • Izumi shares trade on a P/E of 12x, compared with an industry average of 15x and peer average of 17.5x, alongside a 3.04% dividend yield and a DCF fair value estimate of ¥1,293.91 per share versus the current share price of ¥986.
  • What is interesting for a more cautious, bearish take is that while the stock appears cheaper than peers on these numbers, earnings and revenue are both forecast to grow more slowly than the referenced JP market averages, with earnings expected to grow about 6.6% per year versus 10.2% for the market and revenue about 2.4% per year versus 6.5%. This can limit how much weight investors put on the apparent discount.
    • Supporters of the cautious view may argue that a P/E of 12x and a share price that sits below the stated DCF fair value level still need to be read alongside the slower forecast growth rates, especially when the broader market is expected to grow earnings and revenue faster than Izumi.
    • Income oriented investors might instead look at the 3.04% dividend yield together with the margin level of 2.9% and trailing net income of ¥17,317 million to judge whether the current payout looks supported by recent profitability, even if top line growth is expected to trail the wider market.

If you want to see how other investors are joining the dots between these numbers and Izumi's story over time, it is worth checking what the broader community has been focusing on through the narrative tools available on the platform Curious how numbers become stories that shape markets? Explore Community Narratives

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Izumi's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

If this mix of cautious and optimistic signals around Izumi feels finely balanced, it makes sense to review the figures directly and act while sentiment is still forming. To see the specific positives that investors are focused on, check the 5 key rewards.

See What Else Is Out There Beyond Izumi

Izumi still faces questions around its slower forecast earnings and revenue growth compared with the broader JP market and its weaker five year EPS record.

If you want stocks where growth potential and valuation may look more aligned, check out the 15 high quality undervalued stocks to quickly spot ideas that could better fit your expectations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.